Annual Total Long Term Liabilities
$0.00
-$1.37 M-100.00%
December 31, 2023
Summary
- As of February 7, 2025, CRVS annual total long term liabilities is $0.00, with the most recent change of -$1.37 million (-100.00%) on December 31, 2023.
- During the last 3 years, CRVS annual total long term liabilities has fallen by -$1.23 million (-100.00%).
- CRVS annual total long term liabilities is now -100.00% below its all-time high of $126.49 million, reached on December 31, 2015.
Performance
CRVS Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$0.00
$0.000.00%
September 30, 2024
Summary
- As of February 7, 2025, CRVS quarterly total long term liabilities is $0.00, unchanged on September 30, 2024.
- Over the past year, CRVS quarterly long term liabilities has dropped by -$354.00 thousand (-100.00%).
- CRVS quarterly long term liabilities is now -100.00% below its all-time high of $126.49 million, reached on December 31, 2015.
Performance
CRVS Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
CRVS Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -100.0% | -100.0% |
| 3 y3 years | -100.0% | -100.0% |
| 5 y5 years | -100.0% | -100.0% |
CRVS Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -100.0% | at low | -100.0% | at low |
| 5 y | 5-year | -100.0% | at low | -100.0% | at low |
| alltime | all time | -100.0% | at low | -100.0% | at low |
Corvus Pharmaceuticals Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $0.00(0.0%) |
| Jun 2024 | - | $0.00(0.0%) |
| Mar 2024 | - | $0.00(0.0%) |
| Dec 2023 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sep 2023 | - | $354.00 K(-49.4%) |
| Jun 2023 | - | $700.00 K(-32.7%) |
| Mar 2023 | - | $1.04 M(-24.3%) |
| Dec 2022 | $1.37 M(-47.2%) | $1.37 M(-18.7%) |
| Sep 2022 | - | $1.69 M(-15.5%) |
| Jun 2022 | - | $2.00 M(-13.2%) |
| Mar 2022 | - | $2.30 M(-11.5%) |
| Dec 2021 | $2.60 M(+111.1%) | $2.60 M(-9.4%) |
| Sep 2021 | - | $2.87 M(+354.8%) |
| Jun 2021 | - | $631.00 K(-32.5%) |
| Mar 2021 | - | $935.00 K(-24.1%) |
| Dec 2020 | $1.23 M(-46.7%) | $1.23 M(-18.5%) |
| Sep 2020 | - | $1.51 M(-15.3%) |
| Jun 2020 | - | $1.78 M(-13.0%) |
| Mar 2020 | - | $2.05 M(-11.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | $2.31 M(+165.8%) | $2.31 M(-9.0%) |
| Sep 2019 | - | $2.54 M(-8.0%) |
| Jun 2019 | - | $2.76 M(-7.3%) |
| Mar 2019 | - | $2.98 M(+242.6%) |
| Dec 2018 | $869.00 K(-10.5%) | $869.00 K(+38.6%) |
| Sep 2018 | - | $627.00 K(-15.4%) |
| Jun 2018 | - | $741.00 K(-13.5%) |
| Mar 2018 | - | $857.00 K(-11.7%) |
| Dec 2017 | $971.00 K(-30.9%) | $971.00 K(-9.8%) |
| Sep 2017 | - | $1.08 M(-9.3%) |
| Jun 2017 | - | $1.19 M(-8.5%) |
| Mar 2017 | - | $1.30 M(-7.7%) |
| Dec 2016 | $1.41 M(-98.9%) | $1.41 M(+11.8%) |
| Sep 2016 | - | $1.26 M(-6.6%) |
| Jun 2016 | - | $1.35 M(+4.3%) |
| Mar 2016 | - | $1.29 M(-99.0%) |
| Dec 2015 | $126.49 M(+1163.1%) | $126.49 M(+0.4%) |
| Sep 2015 | - | $126.03 M |
| Dec 2014 | $10.01 M | - |
FAQ
- What is Corvus Pharmaceuticals annual total long term liabilities?
- What is the all time high annual total long term liabilities for Corvus Pharmaceuticals?
- What is Corvus Pharmaceuticals annual total long term liabilities year-on-year change?
- What is Corvus Pharmaceuticals quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Corvus Pharmaceuticals?
- What is Corvus Pharmaceuticals quarterly long term liabilities year-on-year change?
What is Corvus Pharmaceuticals annual total long term liabilities?
The current annual total long term liabilities of CRVS is $0.00
What is the all time high annual total long term liabilities for Corvus Pharmaceuticals?
Corvus Pharmaceuticals all-time high annual total long term liabilities is $126.49 M
What is Corvus Pharmaceuticals annual total long term liabilities year-on-year change?
Over the past year, CRVS annual total long term liabilities has changed by -$1.37 M (-100.00%)
What is Corvus Pharmaceuticals quarterly total long term liabilities?
The current quarterly long term liabilities of CRVS is $0.00
What is the all time high quarterly long term liabilities for Corvus Pharmaceuticals?
Corvus Pharmaceuticals all-time high quarterly total long term liabilities is $126.49 M
What is Corvus Pharmaceuticals quarterly long term liabilities year-on-year change?
Over the past year, CRVS quarterly total long term liabilities has changed by -$354.00 K (-100.00%)